|
Functionally Blocking JAML Antibodies for the Treatment of Inflammatory Diseases
Application
Functionally blocking anti-human junctional adhesion molecule-like (JAML) antibodies for the treatment of inflammatory diseases, such as inflammatory bowel disease, rheumatoid arthritis, and skin or eye inflammatory diseases.
Key Benefits
Binds with higher affinity and specificity than currently available JAM antibodies based on comparative...
Published: 4/23/2024
Contributor(s): Charles Parkos, Dominique Weber
|